Your browser doesn't support javascript.
loading
Lessons learned from understanding chemotherapy resistance in epithelial tubo-ovarian carcinoma from BRCA1and BRCA2mutation carriers.
Le Page, Cécile; Amuzu, Setor; Rahimi, Kurosh; Gotlieb, Walter; Ragoussis, Jiannis; Tonin, Patricia N.
Afiliação
  • Le Page C; McGill Research Institute of the McGill University Health Center, Montreal, QC, Canada. Electronic address: cecilelepage@yahoo.ca.
  • Amuzu S; McGill Genome Centre, and Department of Human Genetics, McGill University, Montreal, QC, Canada.
  • Rahimi K; Department of Pathology du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.
  • Gotlieb W; Laboratory of Gynecologic Oncology, Lady Davis Research Institute, Jewish General Hospital, Montreal, QC, Canada.
  • Ragoussis J; McGill Genome Centre, and Department of Human Genetics, McGill University, Montreal, QC, Canada.
  • Tonin PN; Departments of Medicine and Human Genetics, McGill University, Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, QC, Canada. Electronic address: patricia.tonin@mcgill.ca.
Semin Cancer Biol ; 77: 110-126, 2021 12.
Article em En | MEDLINE | ID: mdl-32827632

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Proteína BRCA1 / Proteína BRCA2 / Carcinoma Epitelial do Ovário Limite: Animals / Female / Humans Idioma: En Revista: Semin Cancer Biol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Proteína BRCA1 / Proteína BRCA2 / Carcinoma Epitelial do Ovário Limite: Animals / Female / Humans Idioma: En Revista: Semin Cancer Biol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article